SCHILLER BIPHASIC DEFAB defigaurd DG 400

The DEFIGARD 400 is designed for adult and pediatric applications, offering many optional parameters for complete resuscitation and emergency care.

Download Catalogue

EMI Plans

powered by Razorpay
View Easy EMI offers at Checkout
Medikart EMI Banks

292,000

Description

Description

The SCHILLER BIPHASIC DEFIB Defiguard DG 400 is a defibrillator used to treat life-threatening cardiac arrhythmias, including ventricular fibrillation and pulseless ventricular tachycardia. It is designed to deliver biphasic waveform shocks, which have been shown to be more effective than monophasic shocks at restoring normal heart rhythm.

The Defiguard DG 400 features intuitive controls and a clear display, making it easy for healthcare professionals to use in emergency situations. It also has a rechargeable battery, allowing for reliable and portable use.

In addition to defibrillation, the Defiguard DG 400 can also be used for cardioversion, which is a procedure that uses electrical shocks to convert an abnormal heart rhythm back to a normal one. The device is equipped with a synchronized mode for cardioversion, which ensures that the shock is delivered at the appropriate time in the cardiac cycle.

Overall, the SCHILLER BIPHASIC DEFIB Defiguard DG 400 is a reliable and effective tool for treating life-threatening cardiac arrhythmias and restoring normal heart rhythm in emergency situations.

FAQs (0)

FAQs

Product details

Made possible by exploring innovative molded plywood techniques, Iskos-Berlin’s Soft Edge Chair blends strong curves with extreme lightness to create a three-dimensionality not usually possible with 2-D plywood.

Description

The SCHILLER BIPHASIC DEFIB Defiguard DG 400 is a defibrillator used to treat life-threatening cardiac arrhythmias, including ventricular fibrillation and pulseless ventricular tachycardia. It is designed to deliver biphasic waveform shocks, which have been shown to be more effective than monophasic shocks at restoring normal heart rhythm.

The Defiguard DG 400 features intuitive controls and a clear display, making it easy for healthcare professionals to use in emergency situations. It also has a rechargeable battery, allowing for reliable and portable use.

In addition to defibrillation, the Defiguard DG 400 can also be used for cardioversion, which is a procedure that uses electrical shocks to convert an abnormal heart rhythm back to a normal one. The device is equipped with a synchronized mode for cardioversion, which ensures that the shock is delivered at the appropriate time in the cardiac cycle.

Overall, the SCHILLER BIPHASIC DEFIB Defiguard DG 400 is a reliable and effective tool for treating life-threatening cardiac arrhythmias and restoring normal heart rhythm in emergency situations.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “SCHILLER BIPHASIC DEFAB defigaurd DG 400”

Your email address will not be published. Required fields are marked *

A Trusted Name in Healthcare Innovation

MediKart HealthCare Systems Pvt. Ltd. was born from a vision—to make quality homecare medical equipment affordable and accessible across India. Backed by a team of professionals with deep roots in medical software and equipment marketing, the company quickly grew from a three-member startup to a nationwide platform serving over 80,000+ clients in the respiratory care segment.

Our unique hybrid B2B/B2C model allows us to serve both medical institutions and individual patients effectively. This dual approach, combined with a strong emphasis on customer education, support, and service, has given us a strategic edge in the Indian healthcare landscape.

Through partnerships with medical professionals, hospitals, homecare providers, and caregivers, we have built a community that trusts MediKart for its commitment to excellence, integrity, and innovation. Our journey, marked by resilience and a passion for technological advancement, continues to drive us forward as a leading provider in the Sleep, Respiratory, and Patient Homecare Market.